Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2008
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1819695B1 Anthranilamide derivatives as insecticides
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors
12/17/2008EP1651623B1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/17/2008EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
12/17/2008EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
12/17/2008EP1417176B1 Substituted anthranilamides for controlling invertebrate pests
12/17/2008EP1385504B1 Method of inhibiting adhesion formation
12/17/2008EP1282609B1 Piperazinedione compounds
12/17/2008EP1222305B1 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008CN101326179A New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
12/17/2008CN101326178A Piperazine derivatives useful as CCR5 antagonists
12/17/2008CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase
12/17/2008CN101326176A Pyridazine compound and use thereof
12/17/2008CN101326175A Polymorphs of a C-MET/HGFR inhibitor
12/17/2008CN101326166A Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
12/17/2008CN101325953A 4-heteroaryl-pyrimidine derivatives and use thereof as protein kinase inhibitors
12/17/2008CN101323609A Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease
12/16/2008US7465808 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid and Na salt; 3-[5-Benzo[1,3]dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazol-3-yl]-2-(3-chloro-phenyl)-acrylic acid; 5-{(S)-2-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-pyrazol-3-yl]-1-m-tolyl-ethyl}-1H-tetrazole
12/16/2008US7465806 N-(1-alkyl-4-piperidinyl)-2-pyrrolecarboxamides, e.g., 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-pyrrole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide; treating vascular restenosis following angioplasty
12/16/2008US7465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
12/16/2008US7465798 Methods and compositions for selectin inhibition
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465747 Fluorescent label compounds
12/16/2008US7465746 Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
12/16/2008US7465745 Cathepsin S inhibitors
12/16/2008US7465744 Triazole compounds and the therapeutic use thereof
12/16/2008US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative
12/16/2008US7465735 crop protection agents for controlling harmful fungi; improved activity; 6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-trifluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber
12/16/2008US7465734 Detecting potential therapeutic agent
12/16/2008US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
12/16/2008US7465731 HDAC inhibitor
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
12/16/2008US7465722 Biphenyl vasopressin agonists
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/16/2008CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
12/16/2008CA2302937C Method for producing (hetero)aromatic hydroxylamines
12/11/2008WO2008151183A1 Heterocyclic compounds and uses thereof
12/11/2008WO2008150217A1 2-amino-5, 5-diaryl-imidazol-4-one analogs for the inhibition of beta-secretase
12/11/2008WO2008149965A1 Pyridone compound
12/11/2008WO2008149382A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/11/2008WO2008149204A1 An improved process for preparing an optically active proton pump inhibitor
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008148889A1 Fungicide heterocyclyl-pyrimidinyl-amino derivatives
12/11/2008WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008WO2008148854A1 Ghrelin modulators
12/11/2008WO2008148710A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity
12/11/2008WO2008148689A1 Prolinamide derivatives as nk3 antagonists
12/11/2008WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/11/2008WO2008119825A3 Imidazolidine carboxamide derivatives as p2x7 modulators
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008099083A3 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
12/11/2008WO2008082009A3 Fused substituted aminopyrrolidine derivative
12/11/2008WO2008034039A3 Novel tetrahydro-isoquinolines
12/11/2008WO2008016522A3 Hiv reverse transcriptase inhibitors
12/11/2008US20080306275 Novel heteroaryl derivative
12/11/2008US20080306272 One-pot methods for preparing cinnamide derivatives
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306240 Process for Amination of Acrylic Macromonomers and Products Therefrom
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306122 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; depression or a mood disorder ; modulation of use-dependent voltage-gated sodium channels
12/11/2008US20080306118 Process for the crystallization of (R) - or (S) - Lansoprazole
12/11/2008US20080306115 Midazole-4-Carboxamide Derivatives For Use As Cb1 Modulators
12/11/2008US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione
12/11/2008US20080306108 Substituted Pyridoxines As Anti-Platelet Agents
12/11/2008US20080306101 Insecticidal Spironindane Derivatives
12/11/2008US20080306100 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
12/11/2008US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
12/11/2008US20080306091 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306084 Substituted Amide Compounds
12/11/2008US20080306083 Biaryl Compounds Useful as Agonists of the Gpr38 Receptor
12/11/2008US20080306080 Neutrophilia inhibitor
12/11/2008US20080306071 Substituted piperidine compounds and methods of their use
12/11/2008US20080306069 Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S
12/11/2008US20080306068 Suppression cytokines, tumor necrosis factor
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306064 Benzimidazole Derivatives
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306055 Heterocyclic Mchr1 Antagonists And Their Use In Therapy
12/11/2008US20080306049 Therapeutic pyrazoloquinoline derivatives
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080306046 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative
12/11/2008US20080305557 Novel Applications of Acridinium Compounds and Derivatives in Homogeneous Assays
12/11/2008US20080305041 Pf4 Pharmacophores and Their Uses
12/11/2008US20080303423 Novel Materials For Organic Electroluminescent Devices
12/11/2008DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound
12/11/2008DE102007025717A1 Arylether-pyridazinonderivate Aryl ether pyridazinone derivatives
12/11/2008CA2693552A1 Pyridone compound
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
1 ... 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 ... 1080